Morningside Healthcare Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Morningside Healthcare Limited - overview
Established
2001
Location
Leicester, -, UK
Primary Industry
Pharmaceuticals
About
Based in the UK and founded in 2001, Morningside Healthcare Limited is a provider of licenced prescription medicines to the NHS and retail pharmacy sectors, as well as international export markets. In September 2022, Aspire Pharma Limited, a portfolio company of H. I. G.
Capital, acquired Morningside Healthcare Limited. Morningside Healthcare provides medicine and tablets such as acarbose, acitretin, tramadol, sukkarto SR, and pyrazinamide. The company offers its services in therapeutic fields including cardiology, dermatology, gynaecology, oncology, rheumatology, and neurology. In addition, the firm provides research and development services for new products for prescribers, pharmacies, and patients.
Current Investors
H.I.G. Capital, Aspire Pharma Limited
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development, Specialty Pharmaceuticals
Website
www.morningsidehealthcare.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Morningside Healthcare Limited - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Morningside Healthcare Limited | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.